Atossa Genetics Names Commercial Partner for Laboratory Services Offered by The National Reference Laboratory for Breast Health [Professional Services Close - Up]
(Professional Services Close - Up Via Acquire Media NewsEdge) Atossa Genetics reported that its subsidiary, The National Reference Laboratory for Breast Health, or the NRLBH, has entered into an agreement with BioVentive for the marketing and promotion of the NRLBH's laboratory services.
According to a release from the Company, the NRLBH is a CLIA- registered laboratory in Seattle, Washington that offers anatomic and clinical pathology services as well as molecular-based testing on a nation-wide basis.
Steven Quay, CEO and President of Atossa said, "Although Atossa has distributors for its medical devices, BioVentive will provide critical marketing services for our laboratory, the NRLBH. BioVentive sales personnel are tenured and highly regarded by the medical community and we look forward to them playing a vital role as the NRLBH develops and commercializes its testing services. BioVentive's 85 strong sales force will offer the NRLBH laboratory services throughout the United States."
Brett Nauta, CEO of BioVentive added, "We are extremely pleased to partner with the NRLBH for the marketing of their laboratory services. Their facilities, tests, and scientists are of the highest quality. We ultimately selected NRLBH based on their customer service commitment to physicians and their patients, which is the most important factor when selecting a reference laboratory."
Atossa Genetics is focused on improving breast health through the development of laboratory services, medical devices and therapeutics.
More information and complete details:
((Comments on this story may be sent to email@example.com))
(c) 2014 ProQuest Information and Learning Company; All Rights Reserved.
[ Back To TMCnet.com's Homepage ]